Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Mutations of MAP1B encoding a microtubule-associated phosphoprotein cause sensorineural hearing loss
Limei Cui, Jing Zheng, Qiong Zhao, Jia-Rong Chen, Hanqing Liu, Guanghua Peng, Yue Wu, Chao Chen, Qiufen He, Haosong Shi, Shankai Yin, Rick A. Friedman, Ye Chen, Min-Xin Guan
Limei Cui, Jing Zheng, Qiong Zhao, Jia-Rong Chen, Hanqing Liu, Guanghua Peng, Yue Wu, Chao Chen, Qiufen He, Haosong Shi, Shankai Yin, Rick A. Friedman, Ye Chen, Min-Xin Guan
View: Text | PDF
Research Article Genetics Otology

Mutations of MAP1B encoding a microtubule-associated phosphoprotein cause sensorineural hearing loss

  • Text
  • PDF
Abstract

The pathophysiology underlying spiral ganglion cell defect–induced deafness remains elusive. Using the whole exome sequencing approach, in combination with functional assays and a mouse disease model, we identified the potentially novel deafness-causative MAP1B gene encoding a highly conserved microtubule-associated protein. Three novel heterozygous MAP1B mutations (c.4198A>G, p.1400S>G; c.2768T>C, p.923I>T; c.5512T>C, p.1838F>L) were cosegregated with autosomal dominant inheritance of nonsyndromic sensorineural hearing loss in 3 unrelated Chinese families. Here, we show that MAP1B is highly expressed in the spiral ganglion neurons in the mouse cochlea. Using otic sensory neuron–like cells, generated by pluripotent stem cells from patients carrying the MAP1B mutation and control subject, we demonstrated that the p.1400S>G mutation caused the reduced levels and deficient phosphorylation of MAP1B, which are involved in the microtubule stability and dynamics. Strikingly, otic sensory neuron–like cells exhibited disturbed dynamics of microtubules, axonal elongation, and defects in electrophysiological properties. Dysfunctions of these derived otic sensory neuron–like cells were rescued by genetically correcting MAP1B mutation using CRISPR/Cas9 technology. Involvement of MAP1B in hearing was confirmed by audiometric evaluation of Map1b heterozygous KO mice. These mutant mice displayed late-onset progressive sensorineural hearing loss that was more pronounced in the high frequencies. The spiral ganglion neurons isolated from Map1b mutant mice exhibited the deficient phosphorylation and disturbed dynamics of microtubules. Map1b deficiency yielded defects in the morphology and electrophysiology of spiral ganglion neurons, but it did not affect the morphologies of cochlea in mice. Therefore, our data demonstrate that dysfunctions of spiral ganglion neurons induced by MAP1B deficiency caused hearing loss.

Authors

Limei Cui, Jing Zheng, Qiong Zhao, Jia-Rong Chen, Hanqing Liu, Guanghua Peng, Yue Wu, Chao Chen, Qiufen He, Haosong Shi, Shankai Yin, Rick A. Friedman, Ye Chen, Min-Xin Guan

×

Figure 7

Map1b+/– mice exhibited the hearing-impaired phenotype.

Options: View larger image (or click on image) Download as PowerPoint

Map1b+/– mice exhibited the hearing-impaired phenotype.
(A) The express...
(A) The expression of SMI-31 and MAP1B in the brain of Map1b–/–, Map1b+/–, and Map1b+/+ mice at P7 using Western blot analysis. (B and C) Histogram quantifying the levels of SMI-31 and MAP1B in WT and Map1b-KO mice. Data are mean ± SEM of triplicates. (D) Representative ABR recordings evoked by click burst at 50 dB SPL of Map1b+/+ (green) and Map1b+/– (red) mice at the age of 4, 8, 16, and 32 weeks. (E) Click (300–3000 Hz) and pure tone (8, 12, 24, 32 kHz) stimuli were presented to anesthetized mice. Significantly higher thresholds of ABR (dB SPL) were recorded in Map1b+/– mice, as compared with those of age-matched Map1b+/+ ones (n = 10, including 5 male and 5 female animals). Data are mean ± SEM of triplicates. (F) DPOAE output of Map1b+/– and WT mice (n = 10, including 5 males and 5 females) at 4, 8, 16, and 32 weeks old. Data are mean ± SEM of triplicates. *P <0.05, **P <0.01, and ****P <0.0001 by 1-way ANOVA followed unpaired Student’s t test in B and C and unpaired Student’s t test in E and F.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts